|
시장보고서
상품코드
1766576
신경보호 시장 : 제품 유형별, 작용기전별, 용도별, 환자 속성별, 성별, 투여 경로별, 판매 채널별, 지역별Neuroprotection Market, By Product Type, By Mechanism of Action, By Application, By Patient Demographics, By Gender, By Route of Administration, By Distribution Channel, By Geography |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
신경보호 시장은 2025년에는 351억 달러로 추정되며, 2032년에는 578억 5,000만 달러에 달할 것으로 예측되며, 2025년부터 2032년까지 연평균 성장률(CAGR) 7.4%로 성장할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 | 2024년 | 2025년 시장 규모 | 351억 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2025-2032년 |
| 예측 기간 : 2025-2032년 CAGR | 7.40% | 2032년 가치 예측 | 578억 5,000만 달러 |
세계 신경보호 시장은 다양한 신경 질환 및 부상으로 인한 손상으로부터 신경계를 보호하는 치료 전략의 개발 및 적용에 중점을 두면서 헬스케어 산업에서 중요한 분야로 부상하고 있습니다. 신경보호는 신경세포 손실의 진행을 예방하거나 완화하여 인지 기능을 유지하고 환자의 예후를 개선하는 것을 목표로 하는 광범위한 접근법을 포함합니다. 이 시장은 알츠하이머병, 파킨슨병, 외상성 뇌손상, 뇌졸중과 같은 신경 질환의 유병률 증가로 인해 연구자, 제약사, 의료 서비스 제공자들로부터 큰 관심을 받고 있습니다. 고령화와 이러한 질환의 부담이 증가함에 따라 효과적인 신경보호 중재에 대한 수요가 급증하면서 이 분야의 혁신과 투자를 촉진하고 있습니다.
시장 역학:
세계 신경보호 시장의 성장은 신경장애 유병률 증가, 고령화 인구 증가, 신경장애 예방에 대한 조기 개입의 중요성에 대한 인식 증가 등 몇 가지 주요 요인에 의해 주도되고 있습니다. 알츠하이머병, 파킨슨병과 같은 신경 퇴행성 질환의 유병률이 증가하면서 신경보호 요법에 대한 수요가 크게 증가하고 있습니다. 또한, 사고 및 스포츠 관련 활동으로 인한 외상성 뇌손상 발생률도 시장 성장에 기여하고 있습니다. 그러나 시장에는 높은 약물 개발 비용과 혈뇌장벽을 넘어 치료제를 전달하는 데 따르는 과제 등 일정한 억제요인이 있습니다.
또한, 신경질환을 조기에 발견할 수 있는 효과적인 진단 도구의 부재는 적시에 개입하고 치료하는 데 걸림돌이 되고 있습니다. 이러한 어려움에도 불구하고, 시장에는 성장과 혁신의 큰 기회가 있습니다. 맞춤 의료에 대한 관심이 높아지고 표적 치료의 개발은 신경보호에 유망한 길을 제공합니다. 유전체학, 단백질체학, 바이오마커 탐색의 발전은 새로운 신약 표적 발굴과 정밀 치료법 개발에 새로운 가능성을 열어주고 있습니다. 또한, 학계, 산업계, 정부 기관 간의 협력이 강화되면서 연구개발 노력을 촉진하고 전임상시험에서 얻은 지식을 임상 적용에 적용하는 데 가속도가 붙고 있습니다.
본 조사의 주요 특징
- 세계의 신경보호 시장을 상세히 분석했으며, 2024년을 기준 연도로 하여 예측 기간(2025-2032년)의 시장 규모(10억 달러)와 연평균 성장률(CAGR)에 대해 조사 분석하여 전해드립니다.
- 또한, 다양한 부문에 걸친 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 중요한 인사이트를 제공합니다.
- 이 보고서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 등의 매개 변수를 기반으로 세계 신경보호 시장의 주요 기업을 프로파일링합니다.
- 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대, 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- 세계 신경보호 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 신경보호 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있습니다.
목차
제1장 조사 목적과 가정
- 조사 목적
- 가정
- 약어
제2장 시장 전망
- 보고서 설명
- 시장 정의와 범위
- 주요 요약
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 성장 촉진요인
- 성장 억제요인
- 기회
- 영향 분석
- 주요 발전
- 규제 시나리오
- 제품 발매/승인
- PEST 분석
- PORTER의 분석
- 인수합병 시나리오
- 업계 동향
제4장 세계의 신경보호 시장, 제품 유형별, 2020-2032년
- 의약품
- 생물학적 제제
- 식이보충제
- 기타
제5장 세계의 신경보호 시장, 작용기전별, 2020-2032년
- 항산화물질
- 항염증제
- 신경전달물질 조절약
- 칼슘 채널 차단제
- NMDA 수용체 길항제
- 기타
제6장 세계의 신경보호 시장, 용도별, 2020-2032년
- 알츠하이머병
- 파킨슨병
- 다발성 경화증
- 근위축성측색경화증(ALS)
- 헌팅턴병
- 외상성 뇌손상(TBI)
- 허혈성 뇌졸중
- 간질
- 망막 변성
- 녹내장
- 척수 손상
- 기타
제7장 세계의 신경보호 시장, 환자 속성별, 2020-2032년
- 소아 환자
- 성인 환자
- 고령 환자
제8장 세계의 신경보호 시장, 성별, 2020-2032년
- 남성
- 여성
제9장 세계의 신경보호 시장, 투여 경로별, 2020-2032년
- 경구
- 주사제
- 비강내
- 경피
- 설하
제10장 세계의 신경보호 시장, 유통 채널별, 2020-2032년
- 병원 약국
- 소매 약국
- 온라인 약국
제11장 세계의 신경보호 시장, 지역별, 2020-2032년
- 북미
- 미국
- 캐나다
- 라틴아메리카
- 브라질
- 아르헨티나
- 멕시코
- 기타 라틴아메리카
- 유럽
- 독일
- 영국
- 스페인
- 프랑스
- 이탈리아
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- 호주
- 한국
- ASEAN
- 기타 아시아태평양
- 중동
- GCC 국가
- 이스라엘
- 기타 중동
- 아프리카
- 남아프리카공화국
- 북아프리카
- 중앙아프리카
제12장 경쟁 구도
- Biogen Inc.
- Amgen Inc.
- Novartis AG
- Eli Lilly and Company
- Roche Holding AG
- Pfizer Inc.
- Sanofi S.A.
- Merck & Co., Inc.
- AstraZeneca PLC
- Teva Pharmaceutical Industries Ltd.
- Johnson & Johnson
- AbbVie Inc.
- GSK(GlaxoSmithKline)
- Takeda Pharmaceutical Company Limited
- UCB S.A.
제13장 애널리스트의 추천사항
- 기회
- 애널리스트의 견해
- Coherent Opportunity Map
제14장 참고문헌과 조사 방법
- 참고문헌
- 조사 방법
- 출판사 소개
Neuroprotection Market is estimated to be valued at USD 35.10 Bn in 2025 and is expected to reach USD 57.85 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.4% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 35.10 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 7.40% | 2032 Value Projection: | USD 57.85 Bn |
The global neuroprotection market has emerged as a vital sector within the healthcare industry, focusing on the development and application of therapeutic strategies to safeguard the nervous system from damage caused by various neurological disorders and injuries. Neuroprotection encompasses a wide range of approaches aimed at preventing or mitigating the progression of neuronal loss, thereby preserving cognitive function and improving patient outcomes. This market has garnered significant attention from researchers, pharmaceutical companies, and healthcare providers due to the increasing prevalence of neurological conditions such as Alzheimer's disease, Parkinson's disease, traumatic brain injury, and stroke. With the growing aging population and the rising burden of these disorders, the demand for effective neuroprotective interventions has surged, driving innovation and investment in this field.
Market Dynamics:
The global neuroprotection market growth is driven by several key factors, including the increasing prevalence of neurological disorders, growing aging population, and rising awareness about the importance of early intervention in preventing neurological damage. The prevalence of neurodegenerative diseases such as Alzheimer's and Parkinson's has been on the rise, creating a significant demand for neuroprotective therapies. Additionally, the incidence of traumatic brain injuries due to accidents and sports-related activities has also contributed to the market growth. However, the market faces certain restraints, such as the high cost of drug development and the challenges associated with delivering therapeutics across the blood-brain barrier.
Moreover, the lack of effective diagnostic tools for early detection of neurological disorders hinders timely intervention and treatment. Despite these challenges, the market presents substantial opportunities for growth and innovation. The increasing focus on personalized medicine and the development of targeted therapies offer promising avenues for neuroprotection. Advancements in genomics, proteomics, and biomarker discovery have opened up new possibilities for identifying novel drug targets and developing precision therapies. Furthermore, the growing collaboration between academia, industry, and government organizations has fostered research and development efforts, accelerating the translation of preclinical findings into clinical applications.
Key features of the study:
- This report provides an in-depth analysis of the global neuroprotection market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global neuroprotection market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Biogen Inc., Amgen Inc., Novartis AG, Eli Lilly and Company, Roche Holding AG, Pfizer Inc., Sanofi S.A., Merck & Co., Inc., AstraZeneca PLC, Teva Pharmaceutical Industries Ltd., Johnson & Johnson, AbbVie Inc., GSK (GlaxoSmithKline), Takeda Pharmaceutical Company Limited, and UCB S.A.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global neuroprotection market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neuroprotection market
Market Segmentation
- Product Type Insights (Revenue, USD Bn, 2020 - 2032)
- Pharmaceuticals
- Biologics
- Nutraceuticals
- Others
- Mechanism Of Action Insights (Revenue, USD Bn, 2020 - 2032)
- Antioxidants
- Anti-inflammatory Drugs
- Neurotransmitter Modulators
- Calcium Channel Blockers
- NMDA Receptor Antagonists
- Others
- Application Insights (Revenue, USD Bn, 2020 - 2032)
- Alzheimer's Disease
- Parkinson's Disease
- Multiple Sclerosis
- Amyotrophic Lateral Sclerosis (ALS)
- Huntington's Disease
- Traumatic Brain Injury (TBI)
- Ischemic Stroke
- Epilepsy
- Retinal Degeneration
- Glaucoma
- Spinal Cord Injuries
- Others
- Patient Demographics Insights (Revenue, USD Bn, 2020 - 2032)
- Pediatric Patients
- Adult Patients
- Geriatric Patients
- Gender Insights (Revenue, USD Bn, 2020 - 2032)
- Male
- Female
- Route Of Administration Insights (Revenue, USD Bn, 2020 - 2032)
- Oral
- Injectable
- Intranasal
- Transdermal
- Sublingual
- Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Biogen Inc.
- Amgen Inc.
- Novartis AG
- Eli Lilly and Company
- Roche Holding AG
- Pfizer Inc.
- Sanofi S.A.
- Merck & Co., Inc.
- AstraZeneca PLC
- Teva Pharmaceutical Industries Ltd.
- Johnson & Johnson
- AbbVie Inc.
- GSK (GlaxoSmithKline)
- Takeda Pharmaceutical Company Limited
- UCB S.A.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Neuroprotection Market, By Product Type
- Global Neuroprotection Market, By Mechanism of Action
- Global Neuroprotection Market, By Application
- Global Neuroprotection Market, By Patient Demographics
- Global Neuroprotection Market, By Gender
- Global Neuroprotection Market, By Route of Administration
- Global Neuroprotection Market, By Distribution Channel
- Global Neuroprotection Market, By Region
3. Market Dynamics, Regulations, And Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Neuroprotection Market, By Product Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Pharmaceuticals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Biologics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Nutraceuticals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Neuroprotection Market, By Mechanism of Action, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Antioxidants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Anti-inflammatory Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Neurotransmitter Modulators
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Calcium Channel Blockers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- NMDA Receptor Antagonists
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Neuroprotection Market, By Application, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Alzheimer's Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Parkinson's Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Multiple Sclerosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Amyotrophic Lateral Sclerosis (ALS)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Huntington's Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Traumatic Brain Injury (TBI)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Ischemic Stroke
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Epilepsy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Retinal Degeneration
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Glaucoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Spinal Cord Injuries
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Neuroprotection Market, By Patient Demographics, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Pediatric Patients
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Adult Patients
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Geriatric Patients
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Neuroprotection Market, By Gender, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Male
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Female
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Neuroprotection Market, By Route of Administration, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Intranasal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Transdermal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Sublingual
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
10. Global Neuroprotection Market, By Distribution Channel, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
11. Global Neuroprotection Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Mechanism of Action, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Mechanism of Action, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Mechanism of Action, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Mechanism of Action, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Mechanism of Action, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Mechanism of Action, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
12. Competitive Landscape
- Biogen Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Amgen Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Roche Holding AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sanofi S.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AstraZeneca PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AbbVie Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GSK (GlaxoSmithKline)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Takeda Pharmaceutical Company Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- UCB S.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
13. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
14. References and Research Methodology
- References
- Research Methodology
- About us
샘플 요청 목록